Which app is right for my CVD patient?

Q4 Medicine
I. Gabizon, V. Bhagirath, C. Lokker
{"title":"Which app is right for my CVD patient?","authors":"I. Gabizon, V. Bhagirath, C. Lokker","doi":"10.31887/hm.2020.82/igabizon","DOIUrl":null,"url":null,"abstract":"Cardiovascular disease is a leading cause of mortality and morbidity, and despite efforts to identify and\ncontrol cardiovascular risk factors, significant disease burden remains. As traditional strategies to reduce cardiovascular risk are challenged by lack of resources and growing populations, new strategies are deployed, including\nthe use of smartphone applications (apps) designed to help patients manage their risk factors. For cardiovascular\ndisease, some apps specifically address one risk factor, but others include a more holistic approach to manage\nmultiple risk factors at once for primary and secondary prevention, whereas others serve as virtual cardiac rehabilitation intervention support. App stores show thousands of options in each app category, making it difficult to\nselect the appropriate ones to recommend to patients. Very few apps in the app stores are rigorously validated for\nclinical efficacy or safety, making selection even more challenging. To address this, health organizations worldwide\nhave created platforms to examine and appraise mobile health apps using standardized criteria to support clinician\nand patient app selection decisions. Now, with the rise of the COVID-19 pandemic, prolonged lockdowns have\nchallenged traditional models of care. Telemedicine for cardiovascular disease patients is advancing virtual cardiac\nrehabilitation models to replace or improve traditional care.","PeriodicalId":35477,"journal":{"name":"Heart and Metabolism","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31887/hm.2020.82/igabizon","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiovascular disease is a leading cause of mortality and morbidity, and despite efforts to identify and control cardiovascular risk factors, significant disease burden remains. As traditional strategies to reduce cardiovascular risk are challenged by lack of resources and growing populations, new strategies are deployed, including the use of smartphone applications (apps) designed to help patients manage their risk factors. For cardiovascular disease, some apps specifically address one risk factor, but others include a more holistic approach to manage multiple risk factors at once for primary and secondary prevention, whereas others serve as virtual cardiac rehabilitation intervention support. App stores show thousands of options in each app category, making it difficult to select the appropriate ones to recommend to patients. Very few apps in the app stores are rigorously validated for clinical efficacy or safety, making selection even more challenging. To address this, health organizations worldwide have created platforms to examine and appraise mobile health apps using standardized criteria to support clinician and patient app selection decisions. Now, with the rise of the COVID-19 pandemic, prolonged lockdowns have challenged traditional models of care. Telemedicine for cardiovascular disease patients is advancing virtual cardiac rehabilitation models to replace or improve traditional care.
哪个应用程序适合我的心血管疾病患者?
心血管疾病是死亡率和发病率的主要原因,尽管努力确定和控制心血管危险因素,但仍然存在重大的疾病负担。由于缺乏资源和人口不断增长,降低心血管风险的传统策略受到挑战,因此采用了新的策略,包括使用旨在帮助患者管理其风险因素的智能手机应用程序。对于心血管疾病,一些应用程序专门针对一个风险因素,但其他应用程序包括更全面的方法来同时管理多个风险因素,以进行一级和二级预防,而其他应用程序则提供虚拟心脏康复干预支持。应用商店在每个应用类别中都有数千个选项,因此很难选择合适的推荐给患者。应用程序商店中很少有应用程序经过严格的临床疗效或安全性验证,这使得选择更具挑战性。为了解决这个问题,世界各地的卫生组织已经创建了使用标准化标准检查和评估移动健康应用程序的平台,以支持临床医生和患者的应用程序选择决策。现在,随着COVID-19大流行的兴起,长期封锁对传统的护理模式提出了挑战。心血管疾病患者的远程医疗正在推进虚拟心脏康复模式,以取代或改善传统护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heart and Metabolism
Heart and Metabolism Medicine-Endocrinology, Diabetes and Metabolism
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信